A first-in-class β-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer.
- DOI
- 10.1016/j.ejmech.2024.116283
- Published
- 2024 Apr 5
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2024.116283,
title = {A first-in-class β-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer.},
author = {Otvagin VF and Krylova LV and Peskova NN and Kuzmina NS and Fedotova EA and Nyuchev AV and Romanenko YV and Koifman OI and Vatsadze SZ and Schmalz HG and Balalaeva IV and Fedorov AY},
year = {2024},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2024.116283},
url = {https://doi.org/10.1016/j.ejmech.2024.116283}
}RIS
TY - JOUR TI - A first-in-class β-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer. AU - Otvagin VF AU - Krylova LV AU - Peskova NN AU - Kuzmina NS AU - Fedotova EA AU - Nyuchev AV AU - Romanenko YV AU - Koifman OI AU - Vatsadze SZ AU - Schmalz HG AU - Balalaeva IV AU - Fedorov AY PY - 2024 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2024.116283 UR - https://doi.org/10.1016/j.ejmech.2024.116283 ER -
APA
VF, O., LV, K., NN, P., NS, K., EA, F., AV, N., YV, R., OI, K., SZ, V., HG, S., IV, B., & AY, F. (2024). A first-in-class β-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2024.116283
Source records
- pubmed · retrieved 2026-09-25T22:24:28.528Z